Pharma & Healthcare
Global Inactivated Poliovirus Vaccine Market Research Report 2025
- Sep 09, 25
- ID: 497260
- Pages: 74
- Figures: 74
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inactivated Poliovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Poliovirus Vaccine.
The Inactivated Poliovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Poliovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Poliovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Segment by Type
Human Diploid Cell
Monkey Kidney Cell
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inactivated Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Inactivated Poliovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Poliovirus Vaccine.
The Inactivated Poliovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inactivated Poliovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inactivated Poliovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Segment by Type
Human Diploid Cell
Monkey Kidney Cell
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inactivated Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inactivated Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Inactivated Poliovirus Vaccine Market Overview
1.1 Product Definition
1.2 Inactivated Poliovirus Vaccine by Type
1.2.1 Global Inactivated Poliovirus Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Diploid Cell
1.2.3 Monkey Kidney Cell
1.3 Inactivated Poliovirus Vaccine by Application
1.3.1 Global Inactivated Poliovirus Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Inactivated Poliovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Poliovirus Vaccine Revenue 2020-2031
1.4.2 Global Inactivated Poliovirus Vaccine Sales 2020-2031
1.4.3 Global Inactivated Poliovirus Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inactivated Poliovirus Vaccine Market Competition by Manufacturers
2.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inactivated Poliovirus Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inactivated Poliovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inactivated Poliovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Poliovirus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Inactivated Poliovirus Vaccine, Date of Enter into This Industry
2.8 Global Inactivated Poliovirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Inactivated Poliovirus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inactivated Poliovirus Vaccine Players Market Share by Revenue
2.8.3 Global Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inactivated Poliovirus Vaccine Market Scenario by Region
3.1 Global Inactivated Poliovirus Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inactivated Poliovirus Vaccine Sales by Region: 2020-2031
3.2.1 Global Inactivated Poliovirus Vaccine Sales by Region: 2020-2025
3.2.2 Global Inactivated Poliovirus Vaccine Sales by Region: 2026-2031
3.3 Global Inactivated Poliovirus Vaccine Revenue by Region: 2020-2031
3.3.1 Global Inactivated Poliovirus Vaccine Revenue by Region: 2020-2025
3.3.2 Global Inactivated Poliovirus Vaccine Revenue by Region: 2026-2031
3.4 North America Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inactivated Poliovirus Vaccine Sales by Country (2020-2031)
3.4.3 North America Inactivated Poliovirus Vaccine Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inactivated Poliovirus Vaccine Sales by Country (2020-2031)
3.5.3 Europe Inactivated Poliovirus Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Poliovirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Inactivated Poliovirus Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inactivated Poliovirus Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inactivated Poliovirus Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Inactivated Poliovirus Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inactivated Poliovirus Vaccine Sales by Type (2020-2031)
4.1.1 Global Inactivated Poliovirus Vaccine Sales by Type (2020-2025)
4.1.2 Global Inactivated Poliovirus Vaccine Sales by Type (2026-2031)
4.1.3 Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Inactivated Poliovirus Vaccine Revenue by Type (2020-2031)
4.2.1 Global Inactivated Poliovirus Vaccine Revenue by Type (2020-2025)
4.2.2 Global Inactivated Poliovirus Vaccine Revenue by Type (2026-2031)
4.2.3 Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Inactivated Poliovirus Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inactivated Poliovirus Vaccine Sales by Application (2020-2031)
5.1.1 Global Inactivated Poliovirus Vaccine Sales by Application (2020-2025)
5.1.2 Global Inactivated Poliovirus Vaccine Sales by Application (2026-2031)
5.1.3 Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Inactivated Poliovirus Vaccine Revenue by Application (2020-2031)
5.2.1 Global Inactivated Poliovirus Vaccine Revenue by Application (2020-2025)
5.2.2 Global Inactivated Poliovirus Vaccine Revenue by Application (2026-2031)
5.2.3 Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Inactivated Poliovirus Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Inactivated Poliovirus Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Inactivated Poliovirus Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Serum Institute (Bilthoven Biologicals)
6.3.1 Serum Institute (Bilthoven Biologicals) Company Information
6.3.2 Serum Institute (Bilthoven Biologicals) Description and Business Overview
6.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Portfolio
6.3.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
6.4 IMBCA
6.4.1 IMBCA Company Information
6.4.2 IMBCA Description and Business Overview
6.4.3 IMBCA Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 IMBCA Inactivated Poliovirus Vaccine Product Portfolio
6.4.5 IMBCA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Poliovirus Vaccine Industry Chain Analysis
7.2 Inactivated Poliovirus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Poliovirus Vaccine Production Mode & Process Analysis
7.4 Inactivated Poliovirus Vaccine Sales and Marketing
7.4.1 Inactivated Poliovirus Vaccine Sales Channels
7.4.2 Inactivated Poliovirus Vaccine Distributors
7.5 Inactivated Poliovirus Vaccine Customer Analysis
8 Inactivated Poliovirus Vaccine Market Dynamics
8.1 Inactivated Poliovirus Vaccine Industry Trends
8.2 Inactivated Poliovirus Vaccine Market Drivers
8.3 Inactivated Poliovirus Vaccine Market Challenges
8.4 Inactivated Poliovirus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Inactivated Poliovirus Vaccine by Type
1.2.1 Global Inactivated Poliovirus Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Human Diploid Cell
1.2.3 Monkey Kidney Cell
1.3 Inactivated Poliovirus Vaccine by Application
1.3.1 Global Inactivated Poliovirus Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Inactivated Poliovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Poliovirus Vaccine Revenue 2020-2031
1.4.2 Global Inactivated Poliovirus Vaccine Sales 2020-2031
1.4.3 Global Inactivated Poliovirus Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inactivated Poliovirus Vaccine Market Competition by Manufacturers
2.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inactivated Poliovirus Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inactivated Poliovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inactivated Poliovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Poliovirus Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Inactivated Poliovirus Vaccine, Date of Enter into This Industry
2.8 Global Inactivated Poliovirus Vaccine Market Competitive Situation and Trends
2.8.1 Global Inactivated Poliovirus Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inactivated Poliovirus Vaccine Players Market Share by Revenue
2.8.3 Global Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inactivated Poliovirus Vaccine Market Scenario by Region
3.1 Global Inactivated Poliovirus Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inactivated Poliovirus Vaccine Sales by Region: 2020-2031
3.2.1 Global Inactivated Poliovirus Vaccine Sales by Region: 2020-2025
3.2.2 Global Inactivated Poliovirus Vaccine Sales by Region: 2026-2031
3.3 Global Inactivated Poliovirus Vaccine Revenue by Region: 2020-2031
3.3.1 Global Inactivated Poliovirus Vaccine Revenue by Region: 2020-2025
3.3.2 Global Inactivated Poliovirus Vaccine Revenue by Region: 2026-2031
3.4 North America Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inactivated Poliovirus Vaccine Sales by Country (2020-2031)
3.4.3 North America Inactivated Poliovirus Vaccine Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inactivated Poliovirus Vaccine Sales by Country (2020-2031)
3.5.3 Europe Inactivated Poliovirus Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Poliovirus Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Inactivated Poliovirus Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inactivated Poliovirus Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inactivated Poliovirus Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Inactivated Poliovirus Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Poliovirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Poliovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inactivated Poliovirus Vaccine Sales by Type (2020-2031)
4.1.1 Global Inactivated Poliovirus Vaccine Sales by Type (2020-2025)
4.1.2 Global Inactivated Poliovirus Vaccine Sales by Type (2026-2031)
4.1.3 Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Inactivated Poliovirus Vaccine Revenue by Type (2020-2031)
4.2.1 Global Inactivated Poliovirus Vaccine Revenue by Type (2020-2025)
4.2.2 Global Inactivated Poliovirus Vaccine Revenue by Type (2026-2031)
4.2.3 Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Inactivated Poliovirus Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inactivated Poliovirus Vaccine Sales by Application (2020-2031)
5.1.1 Global Inactivated Poliovirus Vaccine Sales by Application (2020-2025)
5.1.2 Global Inactivated Poliovirus Vaccine Sales by Application (2026-2031)
5.1.3 Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Inactivated Poliovirus Vaccine Revenue by Application (2020-2031)
5.2.1 Global Inactivated Poliovirus Vaccine Revenue by Application (2020-2025)
5.2.2 Global Inactivated Poliovirus Vaccine Revenue by Application (2026-2031)
5.2.3 Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Inactivated Poliovirus Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Inactivated Poliovirus Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Inactivated Poliovirus Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Serum Institute (Bilthoven Biologicals)
6.3.1 Serum Institute (Bilthoven Biologicals) Company Information
6.3.2 Serum Institute (Bilthoven Biologicals) Description and Business Overview
6.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Portfolio
6.3.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
6.4 IMBCA
6.4.1 IMBCA Company Information
6.4.2 IMBCA Description and Business Overview
6.4.3 IMBCA Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 IMBCA Inactivated Poliovirus Vaccine Product Portfolio
6.4.5 IMBCA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Poliovirus Vaccine Industry Chain Analysis
7.2 Inactivated Poliovirus Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Poliovirus Vaccine Production Mode & Process Analysis
7.4 Inactivated Poliovirus Vaccine Sales and Marketing
7.4.1 Inactivated Poliovirus Vaccine Sales Channels
7.4.2 Inactivated Poliovirus Vaccine Distributors
7.5 Inactivated Poliovirus Vaccine Customer Analysis
8 Inactivated Poliovirus Vaccine Market Dynamics
8.1 Inactivated Poliovirus Vaccine Industry Trends
8.2 Inactivated Poliovirus Vaccine Market Drivers
8.3 Inactivated Poliovirus Vaccine Market Challenges
8.4 Inactivated Poliovirus Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Inactivated Poliovirus Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Inactivated Poliovirus Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Inactivated Poliovirus Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Inactivated Poliovirus Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Inactivated Poliovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Inactivated Poliovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inactivated Poliovirus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Poliovirus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Poliovirus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Poliovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poliovirus Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Poliovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Inactivated Poliovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Inactivated Poliovirus Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Inactivated Poliovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Inactivated Poliovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Inactivated Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Inactivated Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Inactivated Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Inactivated Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Inactivated Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Inactivated Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Inactivated Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Inactivated Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Inactivated Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Inactivated Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Inactivated Poliovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Inactivated Poliovirus Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inactivated Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Inactivated Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Inactivated Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Inactivated Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Inactivated Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Inactivated Poliovirus Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Inactivated Poliovirus Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Type (2020-2025)
Table 59. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Type (2026-2031)
Table 60. Global Inactivated Poliovirus Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Inactivated Poliovirus Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Application (2020-2025)
Table 69. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Sanofi Inactivated Poliovirus Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. GSK Inactivated Poliovirus Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Serum Institute (Bilthoven Biologicals) Company Information
Table 81. Serum Institute (Bilthoven Biologicals) Description and Business Overview
Table 82. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product
Table 84. Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
Table 85. IMBCA Company Information
Table 86. IMBCA Description and Business Overview
Table 87. IMBCA Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. IMBCA Inactivated Poliovirus Vaccine Product
Table 89. IMBCA Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Inactivated Poliovirus Vaccine Distributors List
Table 93. Inactivated Poliovirus Vaccine Customers List
Table 94. Inactivated Poliovirus Vaccine Market Trends
Table 95. Inactivated Poliovirus Vaccine Market Drivers
Table 96. Inactivated Poliovirus Vaccine Market Challenges
Table 97. Inactivated Poliovirus Vaccine Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inactivated Poliovirus Vaccine
Figure 2. Global Inactivated Poliovirus Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inactivated Poliovirus Vaccine Market Share by Type: 2024 & 2031
Figure 4. Human Diploid Cell Product Picture
Figure 5. Monkey Kidney Cell Product Picture
Figure 6. Global Inactivated Poliovirus Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Inactivated Poliovirus Vaccine Market Share by Application: 2024 & 2031
Figure 8. Public
Figure 9. Private
Figure 10. Global Inactivated Poliovirus Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Inactivated Poliovirus Vaccine Market Size (2020-2031) & (US$ Million)
Figure 12. Global Inactivated Poliovirus Vaccine Sales (2020-2031) & (K Units)
Figure 13. Global Inactivated Poliovirus Vaccine Average Price (USD/Unit) & (2020-2031)
Figure 14. Inactivated Poliovirus Vaccine Report Years Considered
Figure 15. Inactivated Poliovirus Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Inactivated Poliovirus Vaccine Players: Market Share by Revenue in Inactivated Poliovirus Vaccine in 2024
Figure 18. Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Inactivated Poliovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Inactivated Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 21. North America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 22. the United States Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Inactivated Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 25. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. Germany Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Inactivated Poliovirus Vaccine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Inactivated Poliovirus Vaccine Revenue Market Share by Region (2020-2031)
Figure 33. China Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Inactivated Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Inactivated Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Inactivated Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Inactivated Poliovirus Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Inactivated Poliovirus Vaccine by Type (2020-2031)
Figure 54. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Inactivated Poliovirus Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Inactivated Poliovirus Vaccine by Application (2020-2031)
Figure 57. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Application (2020-2031)
Figure 58. Inactivated Poliovirus Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Inactivated Poliovirus Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Inactivated Poliovirus Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Inactivated Poliovirus Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Inactivated Poliovirus Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Inactivated Poliovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Inactivated Poliovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inactivated Poliovirus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Poliovirus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Poliovirus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Poliovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poliovirus Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Poliovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Inactivated Poliovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Inactivated Poliovirus Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Inactivated Poliovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Inactivated Poliovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Inactivated Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Inactivated Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Inactivated Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Inactivated Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Inactivated Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Inactivated Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Inactivated Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Inactivated Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Inactivated Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Inactivated Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Inactivated Poliovirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Inactivated Poliovirus Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inactivated Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Inactivated Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Inactivated Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Inactivated Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Inactivated Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Inactivated Poliovirus Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Inactivated Poliovirus Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Type (2020-2025)
Table 59. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Type (2026-2031)
Table 60. Global Inactivated Poliovirus Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Inactivated Poliovirus Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Application (2020-2025)
Table 69. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Sanofi Inactivated Poliovirus Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. GSK Inactivated Poliovirus Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Serum Institute (Bilthoven Biologicals) Company Information
Table 81. Serum Institute (Bilthoven Biologicals) Description and Business Overview
Table 82. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product
Table 84. Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
Table 85. IMBCA Company Information
Table 86. IMBCA Description and Business Overview
Table 87. IMBCA Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. IMBCA Inactivated Poliovirus Vaccine Product
Table 89. IMBCA Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Inactivated Poliovirus Vaccine Distributors List
Table 93. Inactivated Poliovirus Vaccine Customers List
Table 94. Inactivated Poliovirus Vaccine Market Trends
Table 95. Inactivated Poliovirus Vaccine Market Drivers
Table 96. Inactivated Poliovirus Vaccine Market Challenges
Table 97. Inactivated Poliovirus Vaccine Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inactivated Poliovirus Vaccine
Figure 2. Global Inactivated Poliovirus Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inactivated Poliovirus Vaccine Market Share by Type: 2024 & 2031
Figure 4. Human Diploid Cell Product Picture
Figure 5. Monkey Kidney Cell Product Picture
Figure 6. Global Inactivated Poliovirus Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Inactivated Poliovirus Vaccine Market Share by Application: 2024 & 2031
Figure 8. Public
Figure 9. Private
Figure 10. Global Inactivated Poliovirus Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Inactivated Poliovirus Vaccine Market Size (2020-2031) & (US$ Million)
Figure 12. Global Inactivated Poliovirus Vaccine Sales (2020-2031) & (K Units)
Figure 13. Global Inactivated Poliovirus Vaccine Average Price (USD/Unit) & (2020-2031)
Figure 14. Inactivated Poliovirus Vaccine Report Years Considered
Figure 15. Inactivated Poliovirus Vaccine Sales Share by Manufacturers in 2024
Figure 16. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Inactivated Poliovirus Vaccine Players: Market Share by Revenue in Inactivated Poliovirus Vaccine in 2024
Figure 18. Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Inactivated Poliovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Inactivated Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 21. North America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 22. the United States Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Inactivated Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 25. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 26. Germany Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Inactivated Poliovirus Vaccine Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Inactivated Poliovirus Vaccine Revenue Market Share by Region (2020-2031)
Figure 33. China Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Inactivated Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 43. Latin America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Inactivated Poliovirus Vaccine Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Inactivated Poliovirus Vaccine Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Inactivated Poliovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Inactivated Poliovirus Vaccine by Type (2020-2031)
Figure 53. Global Revenue Market Share of Inactivated Poliovirus Vaccine by Type (2020-2031)
Figure 54. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Inactivated Poliovirus Vaccine by Application (2020-2031)
Figure 56. Global Revenue Market Share of Inactivated Poliovirus Vaccine by Application (2020-2031)
Figure 57. Global Inactivated Poliovirus Vaccine Price (USD/Unit) by Application (2020-2031)
Figure 58. Inactivated Poliovirus Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232